Refractory Kawasaki disease: Infliximab or methotrexate therapy?

被引：0
|
作者：
Jae Il Shin
Jae Seung Lee
Jae Young Choi
Dong Soo Kim
Meenakshi Girish
机构：
[1] Yonsei University College of Medicine,Department of Pediatrics
[2] Severance Children’s Hospital,Dept of Pediatrics
[3] NKPSIMS,undefined
来源：
The Indian Journal of Pediatrics | 2009年 / 76卷 / 11期
关键词：
Infliximab; Kawasaki Disease; Coronary Artery Aneurysm; Kawasaki Disease Patient; Tumor Necrosis Factor Alpha Inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1184 / 1184
相关论文
共 50 条
  • [41] Should Infliximab be Used as an Adjuvant to IVIG in the Treatment of Children With Kawasaki Disease Who Are at High Risk for Resistance to Conventional Therapy?
    Davies, Shelby
    Gold-von Simson, Gabrielle
    PEDIATRIC CARDIOLOGY, 2013, 34 (07) : 1756 - 1756
  • [42] Should Infliximab be Used as an Adjuvant to IVIG in the Treatment of Children With Kawasaki Disease Who Are at High Risk for Resistance to Conventional Therapy?
    Shelby Davies
    Gabrielle Gold-von Simson
    Pediatric Cardiology, 2013, 34 : 1756 - 1756
  • [43] Psoriasiform skin lesion and supprative acrodermatitis associated with Kawasaki disease followed by the treatment with infliximab: a case report
    Kishimoto, S.
    Muneuchi, J.
    Takahashi, Y.
    Izu, K.
    Nakano, R.
    Joo, K.
    ACTA PAEDIATRICA, 2010, 99 (07) : 1102 - 1104
  • [44] Low-dose Methotrexate Therapy for Intravenous Immunoglobulin-resistant Kawasaki Disease
    Lee, Taek Jin
    Vim, Ki Hwan
    Chun, Jin-Kyong
    Kim, Dong Soo
    YONSEI MEDICAL JOURNAL, 2008, 49 (05) : 714 - 718
  • [45] Cost-effectiveness analysis of infliximab for the treatment of Kawasaki disease refractory to the initial treatment: A retrospective cohort study
    Takura, Tomoyuki
    Horiuchi, Sayaka
    JOURNAL OF CARDIOLOGY, 2022, 80 (02) : 172 - 178
  • [46] Management of acute and refractory Kawasaki disease
    Tacke, Canine E.
    Burgner, David
    Kuipers, Irene M.
    Kuijpers, Taco W.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (10) : 1203 - 1215
  • [47] Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease:: a controlled pilot study
    Schroeder, Oliver
    Blumenstein, Irina
    Stein, Juergen
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (01) : 11 - 16
  • [48] Utility of Ferritin as a Predictor of the Patients with Kawasaki Disease Refractory to Intravenous Immunoglobulin Therapy
    Yamamoto, Noboru
    Sato, Kaoru
    Hoshina, Takayuki
    Kojiro, Masumi
    Kusuhara, Koichi
    Kusuhara, Koichi
    CIRCULATION, 2015, 131
  • [49] Plasma exchange for refractory Kawasaki disease
    Tomoyuki Imagawa
    Masaaki Mori
    Takako Miyamae
    Shuichi Ito
    Tomoko Nakamura
    Kiyoshi Yasui
    Hirokazu Kimura
    Shumpei Yokota
    European Journal of Pediatrics, 2004, 163 : 263 - 264
  • [50] Utility of Ferritin as a Predictor of the Patients with Kawasaki Disease Refractory to Intravenous Immunoglobulin Therapy
    Yamamoto, Noboru
    Sato, Kaoru
    Hoshina, Takayuki
    Kojiro, Masumi
    Kusuhara, Koichi
    Kusuhara, Koichi
    CIRCULATION, 2015, 131
12345